POSTER SESSION II
Monday, March 19, 2012 — 1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
194
GCB vs. ACB Protein Signature in Mantle Cell Lymphoma (MCL). MUM1 Expression Correlate with Proliferation Index (Ki-67) without Impact on Survival
(1604)
R Zarrin, L Street, F Kosari, P Pournazari, M-T Shabani-Rad, J Patel, DA Stewart, A Mansoor - University of Calgary/Calgary Laboratory Services (CLS), Calgary, AB, Canada; University of Calgary, Calgary, AB, Canada
Dysregulated MYC Expression in Aggressive Mantle Cell Lymphomas
(1457)
MJ Kluk, P Sinha, P Dal Cin, SJ Rodig - Brigham and Women´s Hospital, Boston, MA
SOX11 Is Useful To Differentiate Cyclin D1+ Diffuse Large B-Cell Lymphoma from Mantle Cell Lymphoma
(1430)
S-C Hsiao, I Ribera, H Ye, H Liu, S-T Chang, E Campo, S-S Chuang - St. Martin de Porres Hospital, Chia-Yi, Taiwan; University of Barcelona, Barcelona, Spain; University College London, London, United Kingdom; University of Cambridge, Cambridge, United Kingdom; Chi-Mei Medical Center, Tainan, Taiwan
Molecular Characteristics of Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
(1613)
Y Zhou, R Kanagal-Shamanna, S Hoeller, A Tzankov, D Hoehn, SH Swerdlow, A Rosenwald, ZY Xu-Monette, RN Miranda, C Bueso-Ramos, LJ Medeiros, KH Young - The University of Texas MD Anderson Cancer Center, Houston, TX; University of Basel Hospital, Basel, Switzerland; University of Pittsburgh School of Medicine, Pittsburgh, PA; University of Würzburg, Würzburg, Germany
CD38 Expression Density in the Phenotypic Differential Diagnosis of Mantle Cell Lymphoma, CD38+ Chronic Lymphocytic Leukemia and Marginal Zone Lymphoma
(1561)
K Stallings, S El Amin, S Pirruccello - University of Nebraska Medical Center, Omaha, NE
Immunoglobulin Heavy Chain Variable Region (IGHV) Somatic Hypermutation Analysis of Bitypic CLL Cases Detects Prognostically Different Clones with Different Variable Region Segment Usage
(1385)
JF Coleman, GK Olson, J Gale, KE Hunt, MA Vasef - University of New Mexico/TriCore Reference Laboratories, Albuquerque, NM; Henry Ford Hospital, Detroit, MI
Comprehensive Molecular Cytogenetic Analysis by Fluorescence In Situ Hybridization in Patients with Chronic Lymphocytic Leukemia
(1391)
JA Diaz-Perez, D Amaro, ML Dell´Aquila, H-Y Wang - UCSD Moores Cancer Center, La Jolla, CA
Chronic Lymphocytic Leukemia Associated with t(14;18) (q32;q21)
(1571)
G Tang, RL Sargent, JL Medeiros, LV Abruzzo - UT MD Anderson Cancer Center, Houston, TX
In Vivo CLL Proliferation Is Targeted by BTK Inhibition: ERK Activity Predicts Patient Nodal Response
(1584)
YL Wang, S Cheng, J Ma, A Guo, P Lu, L Tyrell, JJ Buggy, JP Leonard, RR Furman - Weill Cornell Medical College, New York, NY; Pharmacyclics Inc., Sunnyvale, CA
Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL): Flow Cytometry (FC) or Immunohistochemistry (IHC)?
(1355)
C Amador-Ortiz, DM Menke, R Valdez, L Jiang, TM Michael, WG Morice, D Jevremovic, TD Shanafelt, CA Hanson - Mayo Clinic, Rochester, MN; Mayo Clinic, Jacksonville, FL; Mayo Clinic, Scottsdale, AZ
Persistence of Residual Normal Peripheral Blood B Cells in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Identifies a Good Prognostic Subgroup
(1428)
P Horna, SH Kroft, AM Harrington, H Olteanu - Medical College of Wisconsin, Milwaukee
Characterization of Tissue Findings in Bone Marrow with Small Monoclonal B-Cell Populations
(1345)
A Abdul-Nabi, L Peterson, B Nelson - Northwestern University, Chicago, IL
Atypical Chronic Lymphocytic Leukemia, Predominantly CD5 Negative with Cytoplasmic Granules
(1357)
S Ayub, B Gehrs, H Jaratli, M Anwar, L Eisenberg, A Al-Katib, M Palutke - Wayne State University/Detroit Medical Center, Detroit, MI
Flow Cytometric Assessment of CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell Lymphoproliferative Disorders
(1517)
V Pillai, O Pozdnyakova, K Charest, B Li, DM Dorfman - Brigham and Women´s Hospital, Boston, MA
Pediatric-Type Follicular Lymphoma Occurs in Both Children and Adults and Is Characterized by a High Proliferation Index and the Absence of a BCL2 Gene Rearrangement
(1483)
A Louissaint, A Ackerman, JA Ferry, AJ Iafrate, LR Zukerberg, NL Harris, RP Hasserjian - Massachusetts General Hospital, Boston, MA
Bcl-2bright Follicular Colonization Pattern Is Not Always Indicative of Incipient or Indolent Follicular Lymphoma
(1468)
JC Lee, V Murty, S Jordan, B Alobeid, B Govind - Columbia University Medical Center, New York, NY
The Efficacy of Lymphoid- Specific Helicase (LSH) and Human Germinal Center Associated Lymphoma (HGAL) in Differentiating Small B Cell Lymphomas
(1611)
M Zheng, M Toscano, E Manaloor - Georgia Health Sciences University, Augusta, GA
In-Situ Follicular Lymphoma: A Case Series with Clinical Characterization and Outcome
(1565)
M Sur, A Rajagopalan, C Ross - McMaster University, Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada
Characterization of Neoangiogenesis and EphrinB2 Expression in Association with CD163+ Macrophages at the Tumor-Host Interface in FL and DLBCL
(1440)
M Jamali, E Hyjek, K Cohen, JW Vardiman - University of Chicago, Chicago, IL
Clonally Related Follicular Lymphoma and Langerhans Cell Neoplasm: A Study of 2 Cases
(1591)
DS West, A Dogan, RP Ketterling, ME Law, ED McPhail, DS Viswanatha, PJ Kurtin, LN Dao, RD Ritzer, GS Nowakowski, AL Feldman - Mayo Clinic, Rochester, MN
Effectiveness of Fine Needle Aspiration and/or Core Needle Biopsy for Subclassifying Follicular Lymphoma and Guiding Initial Treatment Decisions
(1401)
JK Frederiksen, R Burack - University of Rochester Medical Center, Rochester, NY
Software Automated Counting of Ki-67 Proliferation Index Correlates with Pathologic Grade and Disease Progression of Follicular Lymphomas
(1537)
MA Samols, NE Smith, M Vuica-Ross, CD Gocke, KH Burns, MJ Borowitz, TC Cornish, AS Duffield - Johns Hopkins Medical Institutions, Baltimore, MD
Immunoarchitectural Patterns of Germinal Center Antigens Including LMO2 Assist in the Differential Diagnosis of Marginal Zone Lymphoma and Follicular Lymphoma
(1393)
KS Dyhdalo, C Lanigan, RR Tubbs, JR Cook - Cleveland Clinic, Cleveland, OH
Salivary Gland Lymphoproliferative Disorders: A Canadian Experience
(1463)
M Lamba, A Paliga, I Bence-Bruckler, J Farmer - The Ottawa Hospital, Ottawa, Canada
Preclinical Evaluation of Small Molecule p53 Activating Agent Prima-1met in Waldenstrom Macroglobulinemia
(1535)
MN Saha, S Koh, H Chang - University Health Network, Toronto, Canada
Clinicopathologic and Molecular Features of Crystal (Immunoglobulin) Storing Histiocytosis Associated with Lymphoplasmacytic Neoplasms
(1449)
R Kanagal-Shamanna, DM Weber, RZ Orlowski, P Lin, RN Miranda, CE Bueso-Ramos, LJ Medeiros, KH Young - The University of Texas MD Anderson Cancer Center, Houston
Investigation of BRAF Mutations by Pyrosequencing in Lymphomas
(1466)
JA Laurini, P Aoun, J Iqbal, J Chan, TC Greiner - University of Nebraska Medical Center, Omaha, NE
BRAF V600E Mutations in Low Grade B-Cell Lymphomas
(1392)
E Duncavage, L Henke, F Kreisel - Washington University, St. Louis, MO; Washington University School of Medicine, St. Louis, MO
Pyrosequening Analysis for BRAF Mutation in Hairy Cell Leukemia
(1522)
D Qin, L Zhang, L Moscinski, R Setoodeh, S Shen - Moffitt Cancer Center, Tampa, FL
Pyrosequencing of BRAF V600E in Routine Samples of Hairy Cell Leukemia identifies CD5+ Variant Hairy Cell Leukemia That Lacks V600E
(1470)
JK Lennerz, B Klaus, R Marienfeld, P Moeller - University Ulm, Ulm, Germany
BRAF V600E Mutation Is Consistently Absent in Hairy Cell Leukemia Variant: A Retrospective Analysis Using Pyrosequencing
(1452)
P Khalili, D Chabot-Richards, J Gale, MA Vasef - University of New Mexico, Albuquerque, NM; TriCore Reference Laboratories, Albuquerque, NM
DBA.44 Positivity Is Predictive of Hairy Cell Leukemia Variant over Splenic Marginal Zone Lymphoma When Classic Hairy Cell Leukemia Is Excluded
(1372)
DS Chabot-Richards, MH Evans, O Myers, Q-Y Zhang, K Foucar - University of New Mexico, Albuquerque, NM
Annexin A1 (ANXA1), Key Confirmatory Marker Discriminating Hairy Cell Leukemia from Variant Hairy Cell Leukemia and Other Morphologically Similar B-Cell Neoplasms
(1406)
S Gabriel-Griggs, M Bleile, A Bell, N Rosenthal, S Syrbu - University of Iowa, Iowa City, IA
Monoclonality and Cytogenetic Abnormalities in Hyaline- Vascular Castleman´s Disease
(1376)
K-C Chang, I-C Liao, C Chang, H-L Song, D Jones - National Cheng Kung University and Hospital, Tainan, Taiwan; University of Texas M.D. Anderson Cancer Center, Houston, TX
Monoclonal Plasma Cell Proliferations in Castleman Disease: Clinicopathologic and Molecular Analysis
(1349)
NS Aguilera, BK Kim, L Barron, LV Abruzzo, A Auerbach, RL Sargent - Joint Pathology Center, Silver Spring, MD; Armed Forces Institute of Pathology, Washington, DC; University of Texas, M.D. Anderson Cancer Center, Houston, TX
Increased CD5 Positive Polyclonal B-Cells in Castleman Disease, and Lymphoid Hyperplasia with Castleman-Like Features: A Diagnostic Pitfall
(1478)
Q Liu, T Davies-Hill, K Pakzad, M Raffeld, L Xi, S Pittaluga, ES Jaffe - NCI/NIH, Bethesda, MD
Sinus Histiocytosis with Massive Lymphadenopathy (Rosai- Dorfman Disease) Is Not Part of IgG4-Related Sclerosing Disease
(1476)
L Liu, A Perry, W Cao, L Smith, E Hsi, J Mo, S Dotlic, I Damjanov, M Mosunjac, G Talmon, DD Weisenburger, K Fu - University of Nebraska Medical Center, Omaha, NE
Expression of Galectin-1 by EBV-Positive Lymphoproliferative Disorders
(1379)
BJ Chen, J Ouyang, P Sinha, MA Shipp, CDM Fletcher, SJ Rodig - Brigham and Women´s Hospital & Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Boston, MA
Morphologic Changes in Myelodysplastic Syndrome Treated with Hypomethylating Agents
(1526)
SK Rathke, H Olteanu, SH Kroft, AM Harrington - Medical College of Wisconsin, Milwaukee, WI
button next to any title to add to Itinerary Planner...
Add
